A randomized phase 2 study to evaluate the effect of carboplatin with oral vinorelbine (navelbine [Registered Trademark]) followed by maintenance therapy with oral vinorelbine (navelbine [Registered Trademark]) or erlotinib (Tarceva [Registered Trademark]) on quality of life and progression free survival in metastatic non-small cell lung cancer in elderly patients.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Erlotinib (Primary) ; Vinorelbine (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms OMEN
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 16 May 2012 New trial record